ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
    • eNewsletters
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Experts Discuss HPV-Positive Head and Neck Cancer

by Thomas R. Collins • April 21, 2017

  • Tweet
  • Email
Print-Friendly Version

During the 2017 Triological Society Combined Sections Meeting, held January 18–21 in New Orleans, a panel of experts in head and neck cancer discussed the ramifications of the rise in human papillomavirus (HPV)-positive oropharyngeal cancers. Discussion ranged from the value of HPV positivity in identifying unknown primary tumors to the increasing frequency of difficult family conversations after diagnosis of an HPV-positive cancer to issues that will be faced by more and more survivors.

You might also like:

  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • Is it Safe to Kiss in Era of HPV Head and Neck Cancer ‘Epidemic’?
  • HPV Status an Independent Prognostic Factor for Oropharyngeal Cancer Survival
Explore this issue:
April 2017

Christine Gourin, MD, professor of otolaryngology-head and neck surgery at Johns Hopkins University in Baltimore, said that HPV cancers are becoming so much more common that by 2030, it is projected that the most common head and neck mucosal cancer will be HPV-positive oropharyngeal cancer, while the incidence of head and neck cancers arising from other mucosal sites is actually declining. HPV tumors are associated with better survival, as well. “Traditional AJCC [American Joint Committee on Cancer] stage doesn’t seem to apply to that group,” Dr. Gourin said.

Human papillomavirus.

Human papillomavirus.
© Komsan Loonprom / shutterStock.com

David W. Eisele, MD, Andelot professor and director of otolaryngology-head and neck surgery at Johns Hopkins, said that when an adult patient comes in with a solitary neck mass, it is “most likely” going to be cancer, usually squamous cell carcinoma. The earliest diagnostic step shouldn’t be an open-neck biopsy, he said. “Unfortunately, we continue to see patients come in with that procedure having been performed,” he added.

If a nodal metastasis is HPV-related, Dr. Eisele said, it reliably identifies the oropharynx as the site of the primary tumor, often small primaries with advanced nodal disease. HPV status also provides important prognostic information. Pinpointing the primary tumor site improves outcomes, he said.

A 2016 comparison of fine-needle aspiration specimens to resected nodes found that the sensitivity and specificity were “quite good” for linking HPV to the oropharyngeal or the unknown primary patient (J Clin Virol. 2016;85:22–26).

Dr. Eisele emphasized that the presence of p16 protein alone was not a direct marker of high-risk HPV because p16 can be elevated in ways that are not virus-related; histological, anatomic, clinical, and technical factors must be considered.

Dr. Eisele raised concern about proceeding with an initial combination palatine-lingual tonsillectomy approach to identifying the unknown primary, citing studies in which primary tumors were found in the palatine tonsils in many cases, making lingual tonsillectomy, which brings risks for morbidity, unnecessary. (JAMA Otolaryngol Head Neck Surg. 2013;139:1203–1211). Therefore, he said, a sequential approach may be the better choice. Further studies are needed to better define the optimal diagnostic pathway, he concluded.

Treatment De-Intensification

Michael Hinni, MD, an otorhinolaryngologist at the Mayo Clinic in Phoenix, said it’s becoming clear that de-intensifying treatment—using the same intensity of treatment but in a more focused way with less morbidity—is feasible in HPV head and neck oropharyngeal cancers.

Pages: 1 2 3 Single Page

Filed Under: Features, Home Slider Tagged With: head and neck cancer, HPV, HPV-positive cancer, HPV-positive oropharyngeal cancer, radiation, treatment, Triological Society Combined Sections MeetingIssue: April 2017

You might also like:

  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
  • Is it Safe to Kiss in Era of HPV Head and Neck Cancer ‘Epidemic’?
  • HPV Status an Independent Prognostic Factor for Oropharyngeal Cancer Survival

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • How Writing Helps a Medical Resident Better Care for Patients
  • How Physicians Can Build a Network to Boost Their Career
  • How To Survive the First Year of Medical Residency
  • ACGME Revises Cap on Resident Work Hours
  • Ethical Implications of Burnout in Otolaryngology Residents
  • Popular this Week
  • Most Popular
  • Most Recent
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Counseling Patients on Safe Nasal Irrigation
    • Is There a Crisis in the Otolaryngology Match?
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Short-and Long-Term Data Suggest Efficacy of Turbinate Ablation
    • Counseling Patients on Safe Nasal Irrigation
    • Artificial Intelligence and Machine Learning in Otolaryngology
    • Letter from the Editor: Peer Reviewing Sensational Headlines
    • Is Topical Epinephrine Safe for Hemostasis in Endoscopic Sinus Surgery?
    • Is it Safe to Kiss in Era of HPV Head and Neck Cancer ‘Epidemic’?

Polls

Is artificial intelligence an advantage for medicine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy

Visit: The Triological Society • The Laryngoscope • Triological Meeting Posters

Wiley
© 2019 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.